DB
RLYB icon

Danske Bank’s Rallybio RLYB Stock Holding History

Danske Bank’s Portfolio RLYB Stock Details RLYB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16 Hold
1
– – ﹤0.01% 1059
2026
Q1 		$9 Buy
+1
New +$7 ﹤0.01% 1087

Other funds holding RLYB

PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $308M AUM 120.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mariner
Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Danske Bank's RLYB Position: Q2 2026 in Review

Danske Bank held its Rallybio (RLYB) position steady in Q2 2026 at 1 share worth $16. The position accounts for ﹤0.01% of the portfolio, ranked #1059.

Danske Bank first reported a position in RLYB in Q1 2026 and has held it in 2 quarters since. 24 funds tracked by Wall St. Rank hold RLYB as of Q2 2026.

  • Danske Bank held 1 share of Rallybio worth $16 as of Q2 2026.
  • Danske Bank left its Rallybio share count unchanged in Q2 2026.
  • Rallybio made up ﹤0.01% of Danske Bank's portfolio in Q2 2026, its #1059 holding.
  • Danske Bank first reported a position in Rallybio in Q1 2026 and has held it in 2 quarters since.
  • 24 funds tracked by Wall St. Rank held Rallybio as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.